Terms: = Skin cancer AND JAK3, L-JAK, 3718, ENSG00000105639, P52333, JAKL, JAK-3, LJAK, JAK3_HUMAN AND Treatment
10 results:
1. Integrated Safety Analysis of Ritlecitinib, an Oral jak3/TEC Family Kinase Inhibitor, for the treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program.
King B; Soung J; Tziotzios C; Rudnicka L; Joly P; Gooderham M; Sinclair R; Mesinkovska NA; Paul C; Gong Y; Anway SD; Tran H; Wolk R; Zwillich SH; Lejeune A
Am J Clin Dermatol; 2024 Mar; 25(2):299-314. PubMed ID: 38263353
[TBL] [Abstract] [Full Text] [Related]
2. Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance.
Newell F; Pires da Silva I; Johansson PA; Menzies AM; Wilmott JS; Addala V; Carlino MS; Rizos H; Nones K; Edwards JJ; Lakis V; Kazakoff SH; Mukhopadhyay P; Ferguson PM; Leonard C; Koufariotis LT; Wood S; Blank CU; Thompson JF; Spillane AJ; Saw RPM; Shannon KF; Pearson JV; Mann GJ; Hayward NK; Scolyer RA; Waddell N; Long GV
Cancer Cell; 2022 Jan; 40(1):88-102.e7. PubMed ID: 34951955
[TBL] [Abstract] [Full Text] [Related]
3. Advanced-stage mycosis fungoides: role of the signal transducer and activator of transcription 3, nuclear factor-κB and nuclear factor of activated T cells pathways.
Pérez C; Mondéjar R; García-Díaz N; Cereceda L; León A; Montes S; Durán Vian C; Pérez Paredes MG; González-Morán A; Alegre de Miguel V; Sanz Anquela JM; Frias J; Limeres MA; González LM; Martín Dávila F; Beltrán M; Mollejo M; Méndez JR; González MA; González García J; López R; Gómez A; Izquierdo F; Ramos R; Camacho C; Rodriguez-Pinilla SM; Martínez N; Vaqué JP; Ortiz-Romero PL; Piris MA
Br J Dermatol; 2020 Jan; 182(1):147-155. PubMed ID: 31049933
[TBL] [Abstract] [Full Text] [Related]
4. Primary and secondary mucosal melanoma of the small intestine - a clinical, pathological, and genetic nationwide survey of Danish patients between 1980 and 2014.
Tingsgaard JK; Henriksen A; Mikkelsen LH; Behrendt N; Melchior LC; Svendsen LB; Heegaard S
APMIS; 2018 Sep; 126(9):739-745. PubMed ID: 30160023
[TBL] [Abstract] [Full Text] [Related]
5. Aberrant expression of ALK and EZH2 in Merkel cell carcinoma.
Veija T; Koljonen V; Bohling T; Kero M; Knuutila S; Sarhadi VK
BMC Cancer; 2017 Mar; 17(1):236. PubMed ID: 28359267
[TBL] [Abstract] [Full Text] [Related]
6. Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides.
McGirt LY; Jia P; Baerenwald DA; Duszynski RJ; Dahlman KB; Zic JA; Zwerner JP; Hucks D; Dave U; Zhao Z; Eischen CM
Blood; 2015 Jul; 126(4):508-19. PubMed ID: 26082451
[TBL] [Abstract] [Full Text] [Related]
7. Evaluation of antitumor effects of folate-conjugated methyl-β-cyclodextrin in melanoma.
Motoyama K; Onodera R; Tanaka N; Kameyama K; Higashi T; Kariya R; Okada S; Arima H
Biol Pharm Bull; 2015; 38(3):374-9. PubMed ID: 25757918
[TBL] [Abstract] [Full Text] [Related]
8. jak3 and the pathogenesis of severe combined immunodeficiency.
O'Shea JJ; Husa M; Li D; Hofmann SR; Watford W; Roberts JL; Buckley RH; Changelian P; Candotti F
Mol Immunol; 2004 Jul; 41(6-7):727-37. PubMed ID: 15220007
[TBL] [Abstract] [Full Text] [Related]
9. The JAK/STAT pathway is not sufficient to sustain the antiproliferative response in an interferon-resistant human melanoma cell line.
Jackson DP; Watling D; Rogers NC; Banks RE; Kerr IM; Selby PJ; Patel PM
Melanoma Res; 2003 Jun; 13(3):219-29. PubMed ID: 12777975
[TBL] [Abstract] [Full Text] [Related]
10. Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of the SHP-1 promoter.
Zhang Q; Raghunath PN; Vonderheid E; Odum N; Wasik MA
Am J Pathol; 2000 Oct; 157(4):1137-46. PubMed ID: 11021818
[TBL] [Abstract] [Full Text] [Related]